Indo-Rectolmin en es it fr

Categoria

Indo-Rectolmin Nombres de marca, Indo-Rectolmin Analogos

Indo-Rectolmin Marca los nombres de mezcla

  • No information avaliable
  • Indo-Rectolmin Formula quimica

    C19H16ClNO4

    Indo-Rectolmin RX enlace

    http://www.rxlist.com/cgi/generic/indometh.htm

    Indo-Rectolmin FDA hoja

    Indo-Rectolmin MSDS (hoja de seguridad de materiales)

    Indo-Rectolmin MSDS

    Indo-Rectolmin Sintesis de referencia

    No hay información disponible

    Indo-Rectolmin Peso molecular

    357.787 g/mol

    Indo-Rectolmin Punto de fusion

    158 oC

    Indo-Rectolmin H2O Solubilidad

    0,937 mg / L

    Indo-Rectolmin Estado

    Solid

    Indo-Rectolmin LogP

    3.655

    Indo-Rectolmin Formas de dosificacion

    Cápsula

    Indo-Rectolmin Indicacion

    De moderada a severa artritis reumatoide incluyendo brotes agudos de la enfermedad crónica, espondilitis anquilosante, artrosis, hombro doloroso agudo (bursitis y / o tendinitis) y la artritis gotosa aguda.

    Indo-Rectolmin Farmacologia

    Indometacina, un medicamento antiinflamatorio no esteroideo (AINE) con propiedades analgésicas y antipiréticas, se utiliza para tratar la osteoartritis y el control del dolor agudo.

    Indo-Rectolmin Absorcion

    No hay información disponible

    Indo-Rectolmin Toxicidad

    No hay información disponible

    Indo-Rectolmin Informacion de Pacientes

    Indomethacin, like other drugs of its class, is not free of side effects. The side effects of these drugs can cause discomfort and rarely, there are more serious side effects, such as gastrointestinal bleeding, which may result in hospitalization and even fatal outcomes. NSAIDs (Nonsteroidal Anti-Inflammatory Drugs) are often essential agents in the management of arthritis, but they also may be commonly employed for conditions which are less serious. Physicians may wish to discuss with their patients the potential risks and likely benefits of NSAID treatment, particularly when the drugs are used for less serious conditions where treatment without NSAIDs may represent an acceptable alternative to both the patient and physician.

    Indo-Rectolmin Organismos afectados

    Humanos y otros mamíferos